先天性β细胞缺陷与胰岛自身免疫标志物无关,即使在高1型糖尿病遗传风险背景下亦然
本研究检测了242例新生儿糖尿病(NDM)患者及69例无糖尿病对照者的胰岛自身抗体(GADA、IA-2A、ZnT8A)。单基因NDM患者自身抗体阳性率为5.4%,与对照的1.4%相似(p=0.3);β细胞内质网应激组与非应激组阳性率亦无差异(2.7% vs 6.6%,p=0.4)。结论支持β细胞应激/功能障碍本身不导致胰岛自身抗体产生,即使在高危HLA类型背景下亦然。
要点
- 单基因新生儿糖尿病患者胰岛自身抗体阳性率低(13/242,5.4%),与无糖尿病对照(1/69,1.4%)相似(p=0.3)。
- β细胞内质网应激组与非内质网应激病因组的自身抗体阳性率无显著差异(2.7% vs 6.6%,p=0.4)。
- 胰岛自身免疫与遗传风险、检测年龄(包括30例>10岁者)及糖尿病病程均无关联(p>0.4)。
核心结论
- 数据支持β细胞应激/功能障碍本身不导致胰岛自身抗体产生,即使在高危HLA类型背景下亦然,提示触发针对β细胞的自身免疫反应需要额外因素。
研究设计与样本
- 检测242例新生儿糖尿病(NDM)患者(诊断中位年龄1.8个月[IQR 0.39-2.9个月];采集中位年龄4.6个月[IQR 1.8-27.6个月];糖尿病病程中位2个月[IQR 0.6-23个月])的GADA、IA-2A和ZnT8A,其中75例NDM由严重β细胞内质网应激所致。
- 对照队列为69例无糖尿病个体(采集中位年龄9.9个月[IQR 9.0-48.6个月]),同样检测上述自身抗体。
主要发现
- 单基因NDM患者中13/242(5.4%[95%CI 2.9, 9.0%])可检出GADA、IA-2A和/或ZnT8A。
- 无糖尿病对照中1/69阳性(1.4%[95%CI 0.03, 7.8%]),与NDM组相比p=0.3。
- β细胞内质网应激组与非内质网应激病因组的GADA/IA-2A/ZnT8A阳性率分别为2.7%[95%CI 0.3, 9.3%]与6.6%[95%CI 3.3, 11.5%],p=0.4。
- 胰岛自身免疫与遗传风险、检测年龄(包括30例检测时>10岁者)及糖尿病病程均无关联(p>0.4)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: A key unanswered question in type 1 diabetes is whether beta cells initiate their own destruction or are victims of an aberrant immune response (beta cell suicide or homicide?). To investigate this, we assessed islet autoantibodies in individuals with congenital beta cell defects causing neonatal diabetes mellitus (NDM). METHODS: We measured autoantibodies to GAD (GADA), islet antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A) in 242 individuals with NDM (median age diagnosed 1.8 months [IQR 0.39-2.9 months]; median age collected 4.6 months [IQR 1.8-27.6 months]; median diabetes duration 2 months [IQR 0.6-23 months]), including 75 whose NDM resulted from severe beta cell endoplasmic reticulum (ER) stress. As a control cohort we also tested samples from 69 diabetes-free individuals (median age collected 9.9 months [IQR 9.0-48.6 months]) for autoantibodies. RESULTS: We found low prevalence of islet autoantibodies in individuals with monogenic NDM; 13/242 (5.4% [95% CI 2.9, 9.0%]) had detectable GADA, IA-2A and/or ZnT8A. This was similar to the proportion in the control participants who did not have diabetes (1/69 positive [1.4%, 95% CI 0.03, 7.8%], p=0.3). Importantly, monogenic individuals with beta cell ER stress had a similar rate of GADA/IA-2A/ZnT8A positivity to non-ER stress aetiologies (2.7% [95% CI 0.3, 9.3%] vs 6.6% [95% CI 3.3, 11.5%] p=0.4). We observed no association between islet autoimmunity and genetic risk, age at testing (including 30 individuals >10 years at testing) or diabetes duration (p>0.4 for all). CONCLUSIONS/INTERPRETATION: Our data support the hypothesis that beta cell stress/dysfunction alone does not lead to the production of islet autoantibodies, even in the context of high-risk HLA types. This suggests that additional factors are required to trigger an autoimmune response towards beta cells.
引用
- Wyatt RC, Hagopian WA, Roep BO, et al. Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes. Diabetologia. 2022. PMID: 35501400. doi:10.1007/s00125-022-05697-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。